CAPR - Capricor Therapeutics GAAP EPS of -$0.26 beats by $0.05 revenue of $1.59M beats by $1.45M November, 10 2022 04:03 PM Capricor Therapeutics Inc. Capricor Therapeutics press release ( NASDAQ: CAPR ): Q3 GAAP EPS of -$0.26 beats by $0.05 . Revenue of $1.59M beats by $1.45M . For further details see: Capricor Therapeutics GAAP EPS of -$0.26 beats by $0.05, revenue of $1.59M beats by $1.45M